Skip to main content
. 2017 Jun 29;12:1891–1902. doi: 10.2147/COPD.S136768

Table 1.

Demographic and comorbidities data involving 339,389 COPD patients of derivation cohort

Characteristic 2006 2007 2008 2009 2010 2011 Total (%)
N 50,679 50,487 58,786 60,344 59,316 59,777 339,389
Age, years
40–64 14,558 (28.7) 14,900 (29.5) 16,985 (28.9) 18,346 (30.4) 18,080 (30.5) 18,374 (30.7) 101,243 (29.8)
65+ 36,121 (71.3) 35,587 (70.5) 41,801 (71.1) 41,998 (69.6) 41,236 (69.5) 41,403 (69.3) 238,246 (70.2)
Gender
Male 22,356 (44.3) 22,564 (44.8) 26,156 (44.6) 26,755 (44.4) 26,356 (44.5) 26,555 (44.5) 150,742 (44.5)
Female 28,157 (55.7) 27,757 (55.2) 32,476 (55.4) 33,442 (55.6) 32,821 (55.5) 33,097 (55.5) 187,750 (55.5)
Race
Caucasian 37,607 (76.5) 36,704 (74.8) 43,215 (75.2) 44,086 (74.7) 42,791 (73.7) 42,553 (72.6) 246,956 (74.5)
African American 4,864 (9.89) 5,028 (10.2) 5,686 (9.90) 6,169 (10.5) 6,195 (10.7) 6,355 (10.8) 34,297 (10.4)
Other 6,693 (13.6) 7,370 (15.0) 8,555 (14.9) 8,804 (14.9) 9,087 (15.7) 9,692 (16.5) 50,201 (15.2)
Income quartile
1st 13,997 (28.5) 14,282 (29.2) 16,494 (28.9) 17,094 (29.2) 17,305 (30.1) 17,073 (29.5) 96,245 (29.3)
2nd 13,446 (27.4) 13,397 (27.4) 15,773 (27.7) 16,475 (28.2) 15,578 (27.1) 16,153 (27.9) 90,822 (27.6)
3rd 12,170 (24.8) 11,975 (24.5) 13,907 (24.9) 13,879 (23.7) 13,691 (23.8) 14,018 (24.2) 79,640 (24.2)
4th 9,479 (19.3) 9,211 (18.9) 10,860 (19.0) 11,030 (18.9) 10,874 (18.9) 10,694 (18.5) 62,148 (18.9)
Primary payer
Medicaid 5,506 (10.9) 5,895 (11.7) 6,664 (11.3) 7,400 (12.3) 7,469 (12.6) 7,552 (12.6) 40,486 (11.9)
Medicare 36,935 (72.8) 36,065 (71.4) 42,395 (72.1) 43,042 (71.3) 42,762 (72.1) 43,265 (72.4) 244,464 (72.0)
Private insurance 6,513 (12.9) 6,540 (13.0) 7,351 (12.5) 7,360 (12.2) 6,436 (10.9) 6,402 (10.7) 40,602 (12.0)
Self pay 855 (1.69) 1,018 (2.02) 1,177 (2.00) 1,359 (2.25) 1,314 (2.22) 1,226 (2.05) 6,949 (2.05)
Length of stay, days
≤2 13,718 (27.1) 13,779 (27.3) 15,446 (26.3) 16,835 (27.9) 17,508 (29.5) 17,579 (29.4) 94,865 (28.0)
3 8,790 (17.3) 8,859 (17.6) 10,466 (17.8) 10,857 (18.0) 11,061 (18.7) 11,139 (18.6) 61,172 (18.0)
4 7,259 (14.3) 7,178 (14.2) 8,714 (14.8) 8,943 (14.8) 8,654 (14.6) 8,695 (14.6) 49,443 (14.6)
5 5,330 (10.5) 5,330 (10.6) 6,397 (10.9) 6,452 (10.7) 6,100 (10.3) 6,311 (10.6) 35,920 (10.6)
6 3,913 (7.68) 3,882 (7.69) 4,537 (7.72) 4,576 (7.58) 4,409 (7.43) 4,402 (7.36) 25,719 (7.58)
≥7 11,669 (27.1) 11,459 (22.7) 13,226 (22.5) 12,681 (21.0) 11,584 (19.5) 11,651 (19.5) 72,270 (21.3)
Discharge location
Home 30,900 (61.0) 30,831 (61.1) 35,841 (61.0) 36,844 (61.1) 36,148 (60.9) 36,507 (61.1) 207,071 (61.0)
Home health care 8,596 (17.0) 8,452 (16.7) 10,013 (17.0) 10,361 (17.2) 10,766 (18.2) 10,663 (17.8) 58,851 (17.3)
Rehabilitation center/SNF 8,259 (16.3) 8,260 (16.4) 9,673 (16.5) 9,870 (16.4) 9,393 (15.8) 9,582 (16.0) 55,037 (16.2)
Short term hospital 690 (1.36) 696 (1.38) 824 (1.40) 848 (1.41) 720 (1.21) 739 (1.24) 4,517 (1.33)
Other 2,232 (4.40) 2,247 (4.45) 2,415 (4.11) 2,419 (4.01) 2,289 (3.86) 2,283 (3.82) 13,885 (4.09)
Mortalities during admission 1,334 (2.63) 1,305 (2.58) 1,350 (2.30) 1,267 (2.10) 1,083 (1.83) 1,103 (1.85) 7,442 (2.19)
Comorbidities
AIDS 71 (0.14) 77 (0.15) 82 (0.14) 96 (0.16) 81 (0.14) 110 (0.18) 517 (0.15)
Alcohol abuse 1,974 (3.90) 2,012 (3.99) 2,426 (4.13) 2,631 (4.36) 2,728 (4.60) 2,691 (4.50) 14,462 (4.26)
Anemia 7,254 (14.3) 7,814 (15.5) 9,856 (16.8) 10,526 (17.4) 10,379 (17.5) 10,825 (18.1) 56,654 (16.7)
Coagulopathy 800 (1.58) 922 (1.83) 1,226 (2.09) 1,471 (2.44) 1,667 (2.81) 1,869 (3.13) 7,955 (2.34)
Congestive heart failure 12,934 (25.5) 13,249 (26.2) 15,657 (26.6) 16,582 (27.5) 16,235 (27.4) 16,536 (27.7) 91,193 (26.9)
Depression 5,966 (11.8) 6,338 (12.6) 7,143 (12.2) 7,775 (12.9) 7,768 (13.1) 8,195 (13.7) 43,185 (12.7)
Diabetes 12,919 (25.5) 13,520 (26.8) 16,062 (27.3) 17,805 (29.5) 17,729 (29.9) 18,117 (30.3) 96,152 (28.3)
Drug abuse 1,351 (2.67) 1,548 (3.07) 1,636 (2.78) 1,884 (3.12) 2,134 (3.60) 2,353 (3.94) 10,906 (3.21)
Fluid and electrolyte disorder 10,512 (20.7) 10,963 (21.7) 13,521 (23.0) 14,374 (23.8) 14,550 (24.5) 15,503 (25.9) 79,423 (23.4)
Hypertension 29,634 (58.5) 30,491 (60.4) 36,828 (62.7) 38,478 (63.8) 38,955 (65.7) 40,101 (67.1) 214,487 (63.2)
Hypothyroidism 5,835 (11.5) 6,078 (12.0) 7,201 (12.3) 7,852 (13.0) 7,940 (13.4) 8,245 (13.8) 43,151 (12.7)
Liver disease 897 (1.77) 1,022 (2.02) 1,333 (2.27) 1,455 (2.41) 1,569 (2.65) 1,740 (2.91) 8,016 (2.36)
Lymphoma 272 (0.54) 280 (0.55) 377 (0.64) 385 (0.63) 386 (0.65) 400 (0.67) 2,098 (0.62)
Metastatic cancer 708 (1.40) 755 (1.50) 889 (1.51) 943 (1.56) 918 (1.55) 938 (1.57) 5,151 (1.52)
Neurological disorder 3,260 (6.43) 3,612 (7.15) 4,428 (7.53) 4,734 (7.85) 4,685 (7.90) 4,852 (8.12) 25,571 (7.53)
Obesity 4,645 (9.17) 5,012 (9.93) 6,514 (11.1) 7,376 (12.2) 7,490 (12.6) 8,469 (14.2) 39,506 (11.6)
Paralysis 824 (1.63) 766 (1.52) 1,051 (1.79) 996 (1.65) 1,003 (1.69) 958 (1.60) 5,598 (1.65)
Peptic ulcer disease 52 (0.10) 44 (0.09) 43 (0.07) 33 (0.05) 30 (0.05) 32 (0.05) 234 (0.07)
Peripheral vascular disease 3,189 (6.29) 3,386 (6.71) 4,170 (7.09) 4,522 (7.49) 4,797 (8.09) 5,045 (8.44) 25,109 (7.40)
Psychoses 2,792 (5.51) 3,041 (6.02) 3,719 (6.33) 3,949 (6.54) 4,234 (7.14) 4,493 (7.52) 22,228 (6.55)
Pulmonary circulation disorder 234 (0.46) 237 (0.47) 291 (0.50) 326 (0.54) 343 (0.58) 317 (0.53) 1,748 (0.52)
Renal failure 4,221 (8.33) 4,899 (9.70) 6,475 (11.0) 7,429 (12.3) 7,925 (13.4) 8,600 (14.4) 39,549 (11.7)
Rheumatoid arthritis 1,231 (2.43) 1,295 (2.57) 1,619 (2.75) 1,701 (2.82) 1,757 (2.96) 1,842 (3.08) 9,445 (2.78)
Solid tumor without metastasis 1,465 (2.89) 1,506 (2.98) 1,712 (2.91) 1,823 (3.02) 1,852 (3.12) 1,780 (2.98) 10,138 (2.99)
Valvular disease 3,070 (6.06) 3,095 (6.13) 3,684 (6.27) 3,931 (6.51) 3,787 (6.38) 4,143 (6.93) 21,710 (6.40)
Weight loss 1,259 (2.48) 1,268 (2.51) 1,882 (3.20) 2,383 (3.95) 2,629 (4.43) 2,902 (4.85) 12,323 (3.63)

Notes: Anemia combines chronic blood loss anemia and iron deficiency anemia. Diabetes combines complicated and uncomplicated diabetes. Data presented as N (%).

Abbreviations: N, number of patients; SNF, skilled nursing facility.